chr15-101177709-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2
The NM_014918.5(CHSY1):c.2088G>A(p.Thr696Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000497 in 1,614,186 control chromosomes in the GnomAD database, including 8 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0024 ( 4 hom., cov: 33)
Exomes 𝑓: 0.00030 ( 4 hom. )
Consequence
CHSY1
NM_014918.5 synonymous
NM_014918.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.181
Genes affected
CHSY1 (HGNC:17198): (chondroitin sulfate synthase 1) This gene encodes a member of the chondroitin N-acetylgalactosaminyltransferase family. These enzymes possess dual glucuronyltransferase and galactosaminyltransferase activity and play critical roles in the biosynthesis of chondroitin sulfate, a glycosaminoglycan involved in many biological processes including cell proliferation and morphogenesis. Decreased expression of this gene may play a role in colorectal cancer, and mutations in this gene are a cause of temtamy preaxial brachydactyly syndrome. [provided by RefSeq, Dec 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -17 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.56).
BP6
Variant 15-101177709-C-T is Benign according to our data. Variant chr15-101177709-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 283194.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.181 with no splicing effect.
BS2
High Homozygotes in GnomAd4 at 4 AR gene
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CHSY1 | ENST00000254190.4 | c.2088G>A | p.Thr696Thr | synonymous_variant | 3/3 | 1 | NM_014918.5 | ENSP00000254190.3 | ||
CHSY1 | ENST00000543813.2 | n.*1403G>A | non_coding_transcript_exon_variant | 3/3 | 2 | ENSP00000496160.1 | ||||
CHSY1 | ENST00000543813.2 | n.*1403G>A | 3_prime_UTR_variant | 3/3 | 2 | ENSP00000496160.1 |
Frequencies
GnomAD3 genomes AF: 0.00234 AC: 356AN: 152178Hom.: 4 Cov.: 33
GnomAD3 genomes
AF:
AC:
356
AN:
152178
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000561 AC: 141AN: 251290Hom.: 0 AF XY: 0.000390 AC XY: 53AN XY: 135876
GnomAD3 exomes
AF:
AC:
141
AN:
251290
Hom.:
AF XY:
AC XY:
53
AN XY:
135876
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000304 AC: 444AN: 1461890Hom.: 4 Cov.: 48 AF XY: 0.000270 AC XY: 196AN XY: 727248
GnomAD4 exome
AF:
AC:
444
AN:
1461890
Hom.:
Cov.:
48
AF XY:
AC XY:
196
AN XY:
727248
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00236 AC: 359AN: 152296Hom.: 4 Cov.: 33 AF XY: 0.00218 AC XY: 162AN XY: 74466
GnomAD4 genome
AF:
AC:
359
AN:
152296
Hom.:
Cov.:
33
AF XY:
AC XY:
162
AN XY:
74466
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
7
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Oct 02, 2015 | - - |
Temtamy preaxial brachydactyly syndrome Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 16, 2024 | - - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Dec 01, 2022 | CHSY1: BP4, BP7, BS2 - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at